{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T22:17:21Z","timestamp":1768515441695,"version":"3.49.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T00:00:00Z","timestamp":1753401600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/144613\/2019"],"award-info":[{"award-number":["SFRH\/BD\/144613\/2019"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["SFRH\/BD\/135942\/2018"],"award-info":[{"award-number":["SFRH\/BD\/135942\/2018"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UIDP\/04308\/2020"],"award-info":[{"award-number":["UIDP\/04308\/2020"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["EXPL\/MED-FAR\/1065\/2021"],"award-info":[{"award-number":["EXPL\/MED-FAR\/1065\/2021"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Participation of ADP-sensitive metabotropic P2Y<jats:sub>1<\/jats:sub>, P2Y<jats:sub>12<\/jats:sub> and P2Y<jats:sub>13<\/jats:sub> receptors in human osteogenesis is controversial. Here, we investigated the variations in the expression and bone-forming properties of the P2Y<jats:sub>1<\/jats:sub>R in osteogenic-differentiating bone marrow-derived mesenchymal stromal cells (BM-MSCs) isolated from post-menopausal (Pm) women. We also tested whether observed P2Y<jats:sub>1<\/jats:sub>-related functional deficits result from the crosstalk with co-localized P2Y<jats:sub>12<\/jats:sub> and P2Y<jats:sub>13<\/jats:sub> receptors.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Pm BM-MSCs were cultured in an osteogenic-inducing medium in either the absence or presence of the selective P2Y<jats:sub>1<\/jats:sub> receptor agonist, MR2365; this compound was applied alone or after cells\u2019 incubation with selective P2Y<jats:sub>12<\/jats:sub> and P2Y<jats:sub>13<\/jats:sub> receptor antagonists or short hairpin RNAs designed to silence P2Y<jats:sub>12<\/jats:sub> or P2Y<jats:sub>13<\/jats:sub> receptors gene expression.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>BM-MSCs present immunoreactivity against all ADP-sensitive P2Y receptor subtypes, but their relative density varied among different Pm women and with the time of the cells in the culture. The P2Y<jats:sub>1<\/jats:sub>receptor agonist increased the alkaline phosphatase activity and bone nodule formation in BM-MSCs originating from a younger female, but it failed to promote the osteogenic differentiation of BM-MSCs from Pm women unless P2Y<jats:sub>12<\/jats:sub> or P2Y<jats:sub>13<\/jats:sub> receptors are blocked with AR-C66096 and MRS211, respectively. Silencing the P2Y<jats:sub>13<\/jats:sub>, but not the P2Y<jats:sub>12<\/jats:sub>, receptor gene expression restored the P2Y<jats:sub>1<\/jats:sub>-mediated osteogenic commitment of Pm BM-MSCs. The P2Y<jats:sub>1<\/jats:sub> receptor agonist failed to elicit [Ca<jats:sup>2+<\/jats:sup>]<jats:sub>i<\/jats:sub> transients inside Pm BM-MSCs except after acute cholesterol depletion and lipid rafts disruption with methyl-\u03b2-cyclodextrin to prevent the P2Y<jats:sub>1<\/jats:sub>\/P2Y<jats:sub>13<\/jats:sub> receptors interplay.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>Thus, personalized offsetting the activity and\/or expression of P2Y<jats:sub>13<\/jats:sub> receptor (and P2Y<jats:sub>12<\/jats:sub>) may be a good strategy to rehabilitate the P2Y<jats:sub>1<\/jats:sub>-mediated osteogenic potential of BM-MSCs and to reduce the fracture risk in Pm women.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12964-025-02355-0","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:04:16Z","timestamp":1753419856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Silencing P2Y12 and P2Y13 receptors rehabilitates the ADP-induced P2Y1-mediated osteogenic commitment of post-menopausal mesenchymal stromal cells"],"prefix":"10.1186","volume":"23","author":[{"given":"Catarina","family":"Bessa-Andr\u00eas","sequence":"first","affiliation":[]},{"given":"Rui","family":"Pinto-Cardoso","sequence":"additional","affiliation":[]},{"given":"Maria Adelina","family":"Costa","sequence":"additional","affiliation":[]},{"given":"F\u00e1tima","family":"Ferreirinha","sequence":"additional","affiliation":[]},{"given":"Jos\u00e9","family":"Marinhas","sequence":"additional","affiliation":[]},{"given":"Rolando","family":"Freitas","sequence":"additional","affiliation":[]},{"given":"Rui","family":"Lemos","sequence":"additional","affiliation":[]},{"given":"Diogo","family":"Catelas","sequence":"additional","affiliation":[]},{"given":"Ad\u00e9lio","family":"Vila\u00e7a","sequence":"additional","affiliation":[]},{"given":"Ant\u00f3nio","family":"Oliveira","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6114-9189","authenticated-orcid":false,"given":"Paulo","family":"Correia-de-S\u00e1","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6397-2104","authenticated-orcid":false,"given":"Jos\u00e9 Bernardo","family":"Noronha-Matos","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2025,7,25]]},"reference":[{"key":"2355_CR1","doi-asserted-by":"publisher","unstructured":"Consensus. development conference: diagnosis, prophylaxis, and treatment of osteoporosis. Am J Med. 1993;94(6):646\u2013\u200950. https:\/\/doi.org\/10.1016\/0002-9343(93)90218-e","DOI":"10.1016\/0002-9343(93)90218-e"},{"issue":"Suppl 1","key":"2355_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4158\/GL-2020-0524SUPPL","volume":"26","author":"PM Camacho","year":"2020","unstructured":"Camacho PM, Petak SM, Binkley N, et al. American association of clinical endocrinologists\/american college of endocrinology clinical practice guidelines for the diagnosis and treatment of postmenopausal Osteoporosis-2020 update. Endocr Pract. 2020;26(Suppl 1):1\u201346. https:\/\/doi.org\/10.4158\/GL-2020-0524SUPPL","journal-title":"Endocr Pract"},{"issue":"1","key":"2355_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","volume":"16","author":"JA Kanis","year":"2021","unstructured":"Kanis JA, Norton N, Harvey NC, et al. SCOPE 2021: a new scorecard for osteoporosis in Europe. Arch Osteoporos. 2021;16(1):82. https:\/\/doi.org\/10.1007\/s11657-020-00871-9","journal-title":"Arch Osteoporos"},{"issue":"6","key":"2355_CR4","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1016\/j.stem.2012.05.015","volume":"10","author":"A Keating","year":"2012","unstructured":"Keating A. Mesenchymal stromal cells: new directions. Cell Stem Cell. 2012;10(6):709\u201316. https:\/\/doi.org\/10.1016\/j.stem.2012.05.015","journal-title":"Cell Stem Cell"},{"key":"2355_CR5","doi-asserted-by":"publisher","first-page":"121","DOI":"10.22203\/ecm.v020a11","volume":"20","author":"A Augello","year":"2010","unstructured":"Augello A, Kurth TB, De Bari C. Mesenchymal stem cells: a perspective from in vitro cultures to in vivo migration and niches. Eur Cell Mater. 2010;20:121\u201333. https:\/\/doi.org\/10.22203\/ecm.v020a11","journal-title":"Eur Cell Mater"},{"issue":"5","key":"2355_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641\u201350. https:\/\/doi.org\/10.1002\/jor.1100090504","journal-title":"J Orthop Res"},{"key":"2355_CR7","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1186\/s12915-015-0212-7","volume":"13","author":"IR Murray","year":"2015","unstructured":"Murray IR, Peault B. Q&A: mesenchymal stem cells - where do they come from and is it important? BMC Biol. 2015;13:99. https:\/\/doi.org\/10.1186\/s12915-015-0212-7","journal-title":"BMC Biol"},{"issue":"1","key":"2355_CR8","doi-asserted-by":"publisher","first-page":"159","DOI":"10.22074\/cellj.2016.4866","volume":"19","author":"M Emadedin","year":"2017","unstructured":"Emadedin M, Labibzadeh N, Fazeli R, et al. Percutaneous autologous bone Marrow-Derived mesenchymal stromal cell implantation is safe for reconstruction of human lower limb long bone atrophic nonunion. Cell J. 2017;19(1):159\u201365. https:\/\/doi.org\/10.22074\/cellj.2016.4866","journal-title":"Cell J"},{"issue":"3","key":"2355_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.22074\/cellj.2016.4557","volume":"18","author":"N Labibzadeh","year":"2016","unstructured":"Labibzadeh N, Emadedin M, Fazeli R, et al. Mesenchymal stromal cells implantation in combination with platelet lysate product is safe for reconstruction of human long bone nonunion. Cell J. 2016;18(3):302\u20139. https:\/\/doi.org\/10.22074\/cellj.2016.4557","journal-title":"Cell J"},{"issue":"9","key":"2355_CR10","doi-asserted-by":"publisher","first-page":"1852","DOI":"10.1002\/jcp.25303","volume":"231","author":"JB Noronha-Matos","year":"2016","unstructured":"Noronha-Matos JB, Correia-de-S\u00e1 P. Mesenchymal stem cells ageing: targeting the purinome to promote osteogenic differentiation and bone repair. J Cell Physiol. 2016;231(9):1852\u201361. https:\/\/doi.org\/10.1002\/jcp.25303","journal-title":"J Cell Physiol"},{"issue":"4","key":"2355_CR11","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s11302-013-9381-4","volume":"9","author":"G Burnstock","year":"2013","unstructured":"Burnstock G, Arnett TR, Orriss IR. Purinergic signalling in the musculoskeletal system. Purinergic Signal. 2013;9(4):541\u201372. https:\/\/doi.org\/10.1007\/s11302-013-9381-4","journal-title":"Purinergic Signal"},{"issue":"5","key":"2355_CR12","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.bbamcr.2008.01.024","volume":"1783","author":"GG Yegutkin","year":"2008","unstructured":"Yegutkin GG. Nucleotide- and nucleoside-converting ectoenzymes: important modulators of purinergic signalling cascade. Biochim Biophys Acta. 2008;1783(5):673\u201394. https:\/\/doi.org\/10.1016\/j.bbamcr.2008.01.024","journal-title":"Biochim Biophys Acta"},{"issue":"3","key":"2355_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11302-012-9309-4","volume":"8","author":"H Zimmermann","year":"2012","unstructured":"Zimmermann H, Zebisch M, Strater N. Cellular function and molecular structure of ecto-nucleotidases. Purinergic Signal. 2012;8(3):437\u2013502. https:\/\/doi.org\/10.1007\/s11302-012-9309-4","journal-title":"Purinergic Signal"},{"issue":"12","key":"2355_CR14","doi-asserted-by":"publisher","first-page":"5208","DOI":"10.1096\/fj.14-257923","volume":"28","author":"JB Noronha-Matos","year":"2014","unstructured":"Noronha-Matos JB, Coimbra J, S\u00e1-e-Sousa A, et al. P2X7-induced zeiosis promotes osteogenic differentiation and mineralization of postmenopausal bone marrow-derived mesenchymal stem cells. FASEB J. 2014;28(12):5208\u201322. https:\/\/doi.org\/10.1096\/fj.14-257923","journal-title":"FASEB J"},{"issue":"6","key":"2355_CR15","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1002\/jcp.23014","volume":"227","author":"JB Noronha-Matos","year":"2012","unstructured":"Noronha-Matos JB, Costa MA, Magalh\u00e3es-Cardoso MT, et al. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women. J Cell Physiol. 2012;227(6):2694\u2013709. https:\/\/doi.org\/10.1002\/jcp.23014","journal-title":"J Cell Physiol"},{"issue":"1","key":"2355_CR16","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s13287-023-03315-6","volume":"14","author":"JB Noronha-Matos","year":"2023","unstructured":"Noronha-Matos JB, Pinto-Cardoso R, Bessa-Andr\u00eas C, et al. Silencing NTPDase3 activity rehabilitates the osteogenic commitment of post-menopausal stem cell bone progenitors. Stem Cell Res Ther. 2023;14(1):97. https:\/\/doi.org\/10.1186\/s13287-023-03315-6","journal-title":"Stem Cell Res Ther"},{"issue":"5","key":"2355_CR17","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/jcp.22458","volume":"226","author":"MA Costa","year":"2011","unstructured":"Costa MA, Barbosa A, Neto E, et al. On the role of subtype selective adenosine receptor agonists during proliferation and osteogenic differentiation of human primary bone marrow stromal cells. J Cell Physiol. 2011;226(5):1353\u201366. https:\/\/doi.org\/10.1002\/jcp.22458","journal-title":"J Cell Physiol"},{"issue":"2","key":"2355_CR18","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.bone.2009.09.017","volume":"46","author":"EC Alvarenga","year":"2010","unstructured":"Alvarenga EC, Rodrigues R, Caricati-Neto A, et al. Low-intensity pulsed ultrasound-dependent osteoblast proliferation occurs by via activation of the P2Y receptor: role of the P2Y1 receptor. Bone. 2010;46(2):355\u201362. https:\/\/doi.org\/10.1016\/j.bone.2009.09.017","journal-title":"Bone"},{"issue":"7","key":"2355_CR19","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1634\/stemcells.2006-0669","volume":"25","author":"E Coppi","year":"2007","unstructured":"Coppi E, Pugliese AM, Urbani S, et al. ATP modulates cell proliferation and elicits two different electrophysiological responses in human mesenchymal stem cells. Stem Cells. 2007;25(7):1840\u20139. https:\/\/doi.org\/10.1634\/stemcells.2006-0669","journal-title":"Stem Cells"},{"issue":"20","key":"2355_CR20","doi-asserted-by":"publisher","first-page":"14315","DOI":"10.1074\/jbc.274.20.14315","volume":"274","author":"WB Bowler","year":"1999","unstructured":"Bowler WB, Dixon CJ, Halleux C, et al. Signaling in human osteoblasts by extracellular nucleotides. Their weak induction of the c-fos proto-oncogene via Ca2\u2009+\u2009mobilization is strongly potentiated by a parathyroid hormone\/cAMP-dependent protein kinase pathway independently of mitogen-activated protein kinase. J Biol Chem. 1999;274(20):14315\u201324. https:\/\/doi.org\/10.1074\/jbc.274.20.14315","journal-title":"J Biol Chem"},{"issue":"11","key":"2355_CR21","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1002\/jbmr.1690","volume":"27","author":"S Syberg","year":"2012","unstructured":"Syberg S, Brandao-Burch A, Patel JJ, et al. Clopidogrel (Plavix), a P2Y12 receptor antagonist, inhibits bone cell function in vitro and decreases trabecular bone in vivo. J Bone Min Res. 2012;27(11):2373\u201386. https:\/\/doi.org\/10.1002\/jbmr.1690","journal-title":"J Bone Min Res"},{"issue":"10","key":"2355_CR22","doi-asserted-by":"publisher","first-page":"3579","DOI":"10.1172\/JCI38576","volume":"122","author":"X Su","year":"2012","unstructured":"Su X, Floyd DH, Hughes A, et al. The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling. J Clin Invest. 2012;122(10):3579\u201392. https:\/\/doi.org\/10.1172\/JCI38576","journal-title":"J Clin Invest"},{"issue":"4","key":"2355_CR23","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1111\/j.1365-2796.2012.02535.x","volume":"272","author":"NR Jorgensen","year":"2012","unstructured":"Jorgensen NR, Grove EL, Schwarz P, et al. Clopidogrel and the risk of osteoporotic fractures: a nationwide cohort study. J Intern Med. 2012;272(4):385\u201393. https:\/\/doi.org\/10.1111\/j.1365-2796.2012.02535.x","journal-title":"J Intern Med"},{"issue":"1","key":"2355_CR24","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1210\/me.2011-1083","volume":"26","author":"N Wang","year":"2012","unstructured":"Wang N, Robaye B, Agrawal A, et al. Reduced bone turnover in mice lacking the P2Y13 receptor of ADP. Mol Endocrinol. 2012;26(1):142\u201352. https:\/\/doi.org\/10.1210\/me.2011-1083","journal-title":"Mol Endocrinol"},{"key":"2355_CR25","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.2741\/208","volume":"3","author":"I Orriss","year":"2011","unstructured":"Orriss I, Syberg S, Wang N, et al. Bone phenotypes of P2 receptor knockout mice. Front Biosci (Schol Ed). 2011;3:1038\u201346. https:\/\/doi.org\/10.2741\/208","journal-title":"Front Biosci (Schol Ed)"},{"issue":"12","key":"2355_CR26","doi-asserted-by":"publisher","first-page":"2747","DOI":"10.1002\/stem.1411","volume":"31","author":"G Biver","year":"2013","unstructured":"Biver G, Wang N, Gartland A, et al. Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes. Stem Cells. 2013;31(12):2747\u201358. https:\/\/doi.org\/10.1002\/stem.1411","journal-title":"Stem Cells"},{"issue":"24","key":"2355_CR27","doi-asserted-by":"publisher","first-page":"5744","DOI":"10.1111\/bph.13348","volume":"172","author":"SP Alexander","year":"2015","unstructured":"Alexander SP, Davenport AP, Kelly E, et al. The concise guide to PHARMACOLOGY 2015\/16: G protein-coupled receptors. Br J Pharmacol. 2015;172(24):5744\u2013869. https:\/\/doi.org\/10.1111\/bph.13348","journal-title":"Br J Pharmacol"},{"issue":"3","key":"2355_CR28","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1111\/j.1471-4159.2009.06179.x","volume":"110","author":"LM Carrasquero","year":"2009","unstructured":"Carrasquero LM, Delicado EG, Bustillo D, et al. P2X7 and P2Y13 purinergic receptors mediate intracellular calcium responses to BzATP in rat cerebellar astrocytes. J Neurochem. 2009;110(3):879\u201389. https:\/\/doi.org\/10.1111\/j.1471-4159.2009.06179.x","journal-title":"J Neurochem"},{"issue":"1","key":"2355_CR29","doi-asserted-by":"publisher","first-page":"zqaa026","DOI":"10.1093\/function\/zqaa026","volume":"2","author":"O Gryshchenko","year":"2021","unstructured":"Gryshchenko O, Gerasimenko JV, Petersen OH, et al. Calcium signaling in pancreatic immune cells in situ. Function (Oxf). 2021;2(1):zqaa026. https:\/\/doi.org\/10.1093\/function\/zqaa026","journal-title":"Function (Oxf)"},{"issue":"2","key":"2355_CR30","doi-asserted-by":"publisher","first-page":"C266","DOI":"10.1152\/ajpcell.00237.2010","volume":"300","author":"T Lyubchenko","year":"2011","unstructured":"Lyubchenko T, Woodward H, Veo KD, et al. P2Y1 and P2Y13 purinergic receptors mediate Ca2\u2009+\u2009signaling and proliferative responses in pulmonary artery Vasa vasorum endothelial cells. Am J Physiol Cell Physiol. 2011;300(2):C266\u201375. https:\/\/doi.org\/10.1152\/ajpcell.00237.2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"2355_CR31","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.csbj.2015.02.002","volume":"13","author":"R Perez-Sen","year":"2015","unstructured":"Perez-Sen R, Queipo MJ, Morente V, et al. Neuroprotection mediated by P2Y13 nucleotide receptors in neurons. Comput Struct Biotechnol J. 2015;13:160\u20138. https:\/\/doi.org\/10.1016\/j.csbj.2015.02.002","journal-title":"Comput Struct Biotechnol J"},{"issue":"11","key":"2355_CR32","doi-asserted-by":"publisher","first-page":"2240","DOI":"10.1007\/s11064-014-1426-8","volume":"39","author":"J Zeng","year":"2014","unstructured":"Zeng J, Wang G, Liu X, et al. P2Y13 receptor-mediated rapid increase in intracellular calcium induced by ADP in cultured dorsal spinal cord microglia. Neurochem Res. 2014;39(11):2240\u201350. https:\/\/doi.org\/10.1007\/s11064-014-1426-8","journal-title":"Neurochem Res"},{"issue":"6","key":"2355_CR33","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.1182\/blood-2004-02-0534","volume":"104","author":"AR Hardy","year":"2004","unstructured":"Hardy AR, Jones ML, Mundell SJ, et al. Reciprocal cross-talk between P2Y1 and P2Y12 receptors at the level of calcium signaling in human platelets. Blood. 2004;104(6):1745\u201352. https:\/\/doi.org\/10.1182\/blood-2004-02-0534","journal-title":"Blood"},{"key":"2355_CR34","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.2741\/3873","volume":"16","author":"A Wesselius","year":"2011","unstructured":"Wesselius A, Bours MJ, Agrawal A, et al. Role of purinergic receptor polymorphisms in human bone. Front Biosci (Landmark Ed). 2011;16:2572\u201385. https:\/\/doi.org\/10.2741\/3873","journal-title":"Front Biosci (Landmark Ed)"},{"issue":"23","key":"2355_CR35","doi-asserted-by":"publisher","first-page":"17514","DOI":"10.1074\/jbc.M109.053082","volume":"285","author":"S Roger","year":"2010","unstructured":"Roger S, Gillet L, Baroja-Mazo A, et al. C-terminal calmodulin-binding motif differentially controls human and rat P2X7 receptor current facilitation. J Biol Chem. 2010;285(23):17514\u201324. https:\/\/doi.org\/10.1074\/jbc.M109.053082","journal-title":"J Biol Chem"},{"issue":"6","key":"2355_CR36","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/jcp.25656","volume":"232","author":"M Certal","year":"2017","unstructured":"Certal M, Vinhas A, Barros-Barbosa A, et al. ADP-Induced Ca(2+) signaling and proliferation of rat ventricular myofibroblasts depend on phospholipase C-Linked TRP channels activation within lipid rafts. J Cell Physiol. 2017;232(6):1511\u201326. https:\/\/doi.org\/10.1002\/jcp.25656","journal-title":"J Cell Physiol"},{"issue":"1","key":"2355_CR37","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1186\/s13287-024-03775-4","volume":"15","author":"C Bessa-Andres","year":"2024","unstructured":"Bessa-Andres C, Pinto-Cardoso R, Tarasova K, et al. Mechanical stimulation-induced purinome priming fosters osteogenic differentiation and osteointegration of mesenchymal stem cells from the bone marrow of post-menopausal women. Stem Cell Res Ther. 2024;15(1):168. https:\/\/doi.org\/10.1186\/s13287-024-03775-4","journal-title":"Stem Cell Res Ther"},{"key":"2355_CR38","doi-asserted-by":"publisher","unstructured":"Pinto-Cardoso R, Bessa-Andr\u00eas C, Pereira-Costa F, et al. HIF-1\u03b1 stabilisation hampers the chondrogenic differentiation of aged bone marrow mesenchymal stem cells by adenosine A2A\/A2B receptors imbalance. ACS Pharmacol Transl Sci. 2025;in press. https:\/\/doi.org\/10.1021\/acsptsci.5c00190","DOI":"10.1021\/acsptsci.5c00190"},{"issue":"12","key":"2355_CR39","doi-asserted-by":"publisher","first-page":"886","DOI":"10.5966\/sctm.2012-0086","volume":"1","author":"P Lin","year":"2012","unstructured":"Lin P, Lin Y, Lennon DP, et al. Efficient lentiviral transduction of human mesenchymal stem cells that preserves proliferation and differentiation capabilities. Stem Cells Transl Med. 2012;1(12):886\u201397. https:\/\/doi.org\/10.5966\/sctm.2012-0086","journal-title":"Stem Cells Transl Med"},{"issue":"5","key":"2355_CR40","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1016\/j.ceca.2015.08.004","volume":"58","author":"M Certal","year":"2015","unstructured":"Certal M, Vinhas A, Pinheiro AR, et al. Calcium signaling and the novel anti-proliferative effect of the UTP-sensitive P2Y11 receptor in rat cardiac myofibroblasts. Cell Calcium. 2015;58(5):518\u201333. https:\/\/doi.org\/10.1016\/j.ceca.2015.08.004","journal-title":"Cell Calcium"},{"key":"2355_CR41","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/1478-811X-11-70","volume":"11","author":"AR Pinheiro","year":"2013","unstructured":"Pinheiro AR, Paramos-de-Carvalho D, Certal M, et al. Bradykinin-induced Ca2\u2009+\u2009signaling in human subcutaneous fibroblasts involves ATP release via hemichannels leading to P2Y12 receptors activation. Cell Commun Signal. 2013;11:70. https:\/\/doi.org\/10.1186\/1478-811X-11-70","journal-title":"Cell Commun Signal"},{"issue":"1","key":"2355_CR42","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1091\/mbc.01-06-0317","volume":"13","author":"P Thomsen","year":"2002","unstructured":"Thomsen P, Roepstorff K, Stahlhut M, et al. Caveolae are highly immobile plasma membrane microdomains, which are not involved in constitutive endocytic trafficking. Mol Biol Cell. 2002;13(1):238\u201350. https:\/\/doi.org\/10.1091\/mbc.01-06-0317","journal-title":"Mol Biol Cell"},{"key":"2355_CR43","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.neuropharm.2015.12.001","volume":"104","author":"KA Jacobson","year":"2016","unstructured":"Jacobson KA, Muller CE. Medicinal chemistry of adenosine, P2Y and P2X receptors. Neuropharmacology. 2016;104:31\u201349. https:\/\/doi.org\/10.1016\/j.neuropharm.2015.12.001","journal-title":"Neuropharmacology"},{"issue":"1","key":"2355_CR44","doi-asserted-by":"publisher","first-page":"56","DOI":"10.2174\/0929867311302010007","volume":"20","author":"NDA Volonte","year":"2013","unstructured":"Volonte NDA. Metabotropic purinergic receptors in lipid membrane microdomains. Curr Med Chem. 2013;20(1):56\u201363. https:\/\/doi.org\/10.2174\/0929867311302010007","journal-title":"Curr Med Chem"},{"issue":"2","key":"2355_CR45","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1006\/bbrc.1997.7135","volume":"240","author":"R Maier","year":"1997","unstructured":"Maier R, Glatz A, Mosbacher J, et al. Cloning of P2Y6 cDNAs and identification of a pseudogene: comparison of P2Y receptor subtype expression in bone and brain tissues. Biochem Biophys Res Commun. 1997;240(2):298\u2013302. https:\/\/doi.org\/10.1006\/bbrc.1997.7135","journal-title":"Biochem Biophys Res Commun"},{"issue":"11","key":"2355_CR46","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1096\/fj.02-0940com","volume":"17","author":"KA Buckley","year":"2003","unstructured":"Buckley KA, Golding SL, Rice JM, et al. Release and interconversion of P2 receptor agonists by human osteoblast-like cells. FASEB J. 2003;17(11):1401\u201310. https:\/\/doi.org\/10.1096\/fj.02-0940com","journal-title":"FASEB J"},{"issue":"2","key":"2355_CR47","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.bbrc.2004.11.037","volume":"326","author":"H Ihara","year":"2005","unstructured":"Ihara H, Hirukawa K, Goto S, et al. ATP-stimulated interleukin-6 synthesis through P2Y receptors on human osteoblasts. Biochem Biophys Res Commun. 2005;326(2):329\u201334. https:\/\/doi.org\/10.1016\/j.bbrc.2004.11.037","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"2355_CR48","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1096\/fj.00-0395com","volume":"15","author":"A Hoebertz","year":"2001","unstructured":"Hoebertz A, Meghji S, Burnstock G, et al. Extracellular ADP is a powerful osteolytic agent: evidence for signaling through the P2Y(1) receptor on bone cells. FASEB J. 2001;15(7):1139\u201348. https:\/\/doi.org\/10.1096\/fj.00-0395com","journal-title":"FASEB J"},{"issue":"6","key":"2355_CR49","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1002\/wmts.67","volume":"1","author":"IR Orriss","year":"2012","unstructured":"Orriss IR, Arnett TR. P2Y receptors in bone. WIREs Membr Transp Signal. 2012;1(6):805\u201314. https:\/\/doi.org\/10.1002\/wmts.67","journal-title":"WIREs Membr Transp Signal"},{"issue":"2","key":"2355_CR50","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.bone.2006.02.063","volume":"39","author":"IR Orriss","year":"2006","unstructured":"Orriss IR, Knight GE, Ranasinghe S, et al. Osteoblast responses to nucleotides increase during differentiation. Bone. 2006;39(2):300\u20139. https:\/\/doi.org\/10.1016\/j.bone.2006.02.063","journal-title":"Bone"},{"issue":"9","key":"2355_CR51","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1517\/13543780903176415","volume":"18","author":"I Porto","year":"2009","unstructured":"Porto I, Giubilato S, De Maria GL, et al. Platelet P2Y12 receptor Inhibition by thienopyridines: status and future. Expert Opin Investig Drugs. 2009;18(9):1317\u201332. https:\/\/doi.org\/10.1517\/13543780903176415","journal-title":"Expert Opin Investig Drugs"},{"issue":"1","key":"2355_CR52","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.cellsig.2008.09.016","volume":"21","author":"C Malaval","year":"2009","unstructured":"Malaval C, Laffargue M, Barbaras R, et al. RhoA\/ROCK I signalling downstream of the P2Y13 ADP-receptor controls HDL endocytosis in human hepatocytes. Cell Signal. 2009;21(1):120\u20137. https:\/\/doi.org\/10.1016\/j.cellsig.2008.09.016","journal-title":"Cell Signal"},{"issue":"5","key":"2355_CR53","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1359\/jbmr.081240","volume":"24","author":"CB Khatiwala","year":"2009","unstructured":"Khatiwala CB, Kim PD, Peyton SR, et al. ECM compliance regulates osteogenesis by influencing MAPK signaling downstream of RhoA and ROCK. J Bone Min Res. 2009;24(5):886\u201398. https:\/\/doi.org\/10.1359\/jbmr.081240","journal-title":"J Bone Min Res"},{"issue":"6","key":"2355_CR54","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1089\/scd.2010.0576","volume":"21","author":"N Zippel","year":"2012","unstructured":"Zippel N, Limbach CA, Ratajski N, et al. Purinergic receptors influence the differentiation of human mesenchymal stem cells. Stem Cells Dev. 2012;21(6):884\u2013900. https:\/\/doi.org\/10.1089\/scd.2010.0576","journal-title":"Stem Cells Dev"},{"key":"2355_CR55","doi-asserted-by":"publisher","first-page":"418","DOI":"10.3389\/fphar.2018.00418","volume":"9","author":"C Quintas","year":"2018","unstructured":"Quintas C, Vale N, Goncalves J, et al. Microglia P2Y13 receptors prevent astrocyte proliferation mediated by P2Y1 receptors. Front Pharmacol. 2018;9:418. https:\/\/doi.org\/10.3389\/fphar.2018.00418","journal-title":"Front Pharmacol"},{"issue":"3","key":"2355_CR56","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s11302-007-9051-5","volume":"3","author":"D Suplat","year":"2007","unstructured":"Suplat D, Krzeminski P, Pomorski P, et al. P2Y(1) and P2Y(12) receptor cross-talk in calcium signalling: evidence from nonstarved and long-term serum-deprived glioma C6 cells. Purinergic Signal. 2007;3(3):221\u201330. https:\/\/doi.org\/10.1007\/s11302-007-9051-5","journal-title":"Purinergic Signal"},{"key":"2355_CR57","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.mcb.2015.11.008","volume":"132","author":"VA Villar","year":"2016","unstructured":"Villar VA, Cuevas S, Zheng X, et al. Localization and signaling of GPCRs in lipid rafts. Methods Cell Biol. 2016;132:3\u201323. https:\/\/doi.org\/10.1016\/bs.mcb.2015.11.008","journal-title":"Methods Cell Biol"},{"issue":"4","key":"2355_CR58","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1210\/endo.136.4.7895678","volume":"136","author":"AD Kaplan","year":"1995","unstructured":"Kaplan AD, Reimer WJ, Feldman RD, et al. Extracellular nucleotides potentiate the cytosolic Ca2+, but not Cyclic adenosine 3\u2019, 5\u2019-monophosphate response to parathyroid hormone in rat osteoblastic cells. Endocrinology. 1995;136(4):1674\u201385. https:\/\/doi.org\/10.1210\/endo.136.4.7895678","journal-title":"Endocrinology"},{"issue":"10","key":"2355_CR59","doi-asserted-by":"publisher","first-page":"4489","DOI":"10.1210\/endo.136.10.7664669","volume":"136","author":"FD Sistare","year":"1995","unstructured":"Sistare FD, Rosenzweig BA, Contrera JG. P2 purinergic receptors potentiate parathyroid hormone receptor-mediated increases in intracellular calcium and inositol trisphosphate in UMR-106 rat osteoblasts. Endocrinology. 1995;136(10):4489\u201397. https:\/\/doi.org\/10.1210\/endo.136.10.7664669","journal-title":"Endocrinology"},{"issue":"5","key":"2355_CR60","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1016\/s8756-3282(01)00430-6","volume":"28","author":"WB Bowler","year":"2001","unstructured":"Bowler WB, Buckley KA, Gartland A, et al. Extracellular nucleotide signaling: a mechanism for integrating local and systemic responses in the activation of bone remodeling. Bone. 2001;28(5):507\u201312. https:\/\/doi.org\/10.1016\/s8756-3282(01)00430-6","journal-title":"Bone"},{"issue":"13","key":"2355_CR61","doi-asserted-by":"publisher","first-page":"7617","DOI":"10.1073\/pnas.121587098","volume":"98","author":"K Yoshioka","year":"2001","unstructured":"Yoshioka K, Saitoh O, Nakata H. Heteromeric association creates a P2Y-like adenosine receptor. Proc Natl Acad Sci U S A. 2001;98(13):7617\u201322. https:\/\/doi.org\/10.1073\/pnas.121587098","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2355_CR62","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/s0014-5793(02)03540-8","volume":"531","author":"K Yoshioka","year":"2002","unstructured":"Yoshioka K, Hosoda R, Kuroda Y, et al. Hetero-oligomerization of adenosine A1 receptors with P2Y1 receptors in rat brains. FEBS Lett. 2002;531(2):299\u2013303. https:\/\/doi.org\/10.1016\/s0014-5793(02)03540-8","journal-title":"FEBS Lett"},{"issue":"2","key":"2355_CR63","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bbrc.2006.10.075","volume":"351","author":"T Suzuki","year":"2006","unstructured":"Suzuki T, Namba K, Tsuga H, et al. Regulation of Pharmacology by hetero-oligomerization between A1 adenosine receptor and P2Y2 receptor. Biochem Biophys Res Commun. 2006;351(2):559\u201365. https:\/\/doi.org\/10.1016\/j.bbrc.2006.10.075","journal-title":"Biochem Biophys Res Commun"},{"issue":"1","key":"2355_CR64","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1042\/BJ20070671","volume":"409","author":"D Ecke","year":"2008","unstructured":"Ecke D, Hanck T, Tulapurkar ME, et al. Hetero-oligomerization of the P2Y11 receptor with the P2Y1 receptor controls the internalization and ligand selectivity of the P2Y11 receptor. Biochem J. 2008;409(1):107\u201316. https:\/\/doi.org\/10.1042\/BJ20070671","journal-title":"Biochem J"},{"issue":"1","key":"2355_CR65","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/01.ATV.0000148708.44691.27","volume":"25","author":"SL Hetherington","year":"2005","unstructured":"Hetherington SL, Singh RK, Lodwick D, et al. Dimorphism in the P2Y1 ADP receptor gene is associated with increased platelet activation response to ADP. Arterioscler Thromb Vasc Biol. 2005;25(1):252\u20137. https:\/\/doi.org\/10.1161\/01.ATV.0000148708.44691.27","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2355_CR66","doi-asserted-by":"publisher","unstructured":"Janicki PK, Eyileten C, Ruiz-Velasco V, et al. Population-Specific associations of deleterious rare variants in coding region of P2RY1-P2RY12 purinergic receptor genes in Large-Vessel ischemic stroke patients. Int J Mol Sci. 2017;18(12). https:\/\/doi.org\/10.3390\/ijms18122678","DOI":"10.3390\/ijms18122678"},{"issue":"6","key":"2355_CR67","doi-asserted-by":"publisher","first-page":"577","DOI":"10.2217\/14622416.8.6.577","volume":"8","author":"Q Li","year":"2007","unstructured":"Li Q, Chen BL, Ozdemir V, et al. Frequency of genetic polymorphisms of COX1, GPIIIa and P2Y1 in a Chinese population and association with attenuated response to aspirin. Pharmacogenomics. 2007;8(6):577\u201386. https:\/\/doi.org\/10.2217\/14622416.8.6.577","journal-title":"Pharmacogenomics"},{"issue":"4","key":"2355_CR68","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1111\/j.1538-7836.2006.01869.x","volume":"4","author":"D Sibbing","year":"2006","unstructured":"Sibbing D, von Beckerath O, Schomig A, et al. P2Y1 gene A1622G dimorphism is not associated with adenosine diphosphate-induced platelet activation and aggregation after administration of a single high dose of clopidogrel. J Thromb Haemost. 2006;4(4):912\u20134. https:\/\/doi.org\/10.1111\/j.1538-7836.2006.01869.x","journal-title":"J Thromb Haemost"},{"issue":"1","key":"2355_CR69","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.bbrc.2005.04.087","volume":"332","author":"B Cheewatrakoolpong","year":"2005","unstructured":"Cheewatrakoolpong B, Gilchrest H, Anthes JC, et al. Identification and characterization of splice variants of the human P2X7 ATP channel. Biochem Biophys Res Commun. 2005;332(1):17\u201327. https:\/\/doi.org\/10.1016\/j.bbrc.2005.04.087","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02355-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02355-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T05:04:18Z","timestamp":1753419858000},"score":1,"resource":{"primary":{"URL":"https:\/\/biosignaling.biomedcentral.com\/articles\/10.1186\/s12964-025-02355-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,25]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2355"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02355-0","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,25]]},"assertion":[{"value":"16 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Informed consent to use the biological material that would be otherwise discarded was obtained. All procedures were approved within the scope of the project \u201cBONE-PURI(NO)AGEING\u2013 Regeneration of aged human bone through purinome activation in mesenchymal stem cells\u2013 preclinical studies\u201d, followed by the project \u201cBONEREGENERA - New insights of the purinome in predicting bone healing by mesenchymal stromal cells in osteoporotic patients\u201d by the Ethics Committees of Centro Hospitalar de Vila Nova de Gaia\u2013 Espinho (registration n\u00b0 137\/2018-2, endorsed on January 10, 2019) and of Gabinete Coordenador de Investiga\u00e7\u00e3o \/ DEFI\u2013 Centro Hospitalar Universit\u00e1rio de Santo Ant\u00f3nio (CHUdSA, registration n\u00b0 2021-002(001-DEFI-001-CE, endorsed on September 01, 2021), and of Instituto de Ci\u00eancias Biom\u00e9dicas Abel Salazar (Medical School) of the University of Porto. The investigation conforms to the principles outlined in the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"The authors have declared that no conflict of interest exists.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"353"}}